Your browser doesn't support javascript.
loading
Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma.
Huang, Jianfeng; Zou, Qinzhou; Qian, Danqi; Zhou, Leyuan; Yang, Bo; Chu, Jianjun; Pang, Qingfeng; Wang, Kewei; Zhang, Fuzheng.
Affiliation
  • Huang J; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University.
  • Zou Q; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University.
  • Qian D; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University.
  • Zhou L; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University.
  • Yang B; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University.
  • Chu J; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University.
  • Pang Q; Department of Epidemiology, Wuxi Medical School of Jiangnan University, Wuxi, Jiangsu, People's Republic of China.
  • Wang K; Department of Epidemiology, Wuxi Medical School of Jiangnan University, Wuxi, Jiangsu, People's Republic of China.
  • Zhang F; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University.
Onco Targets Ther ; 10: 5835-5841, 2017.
Article in En | MEDLINE | ID: mdl-29263680

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Onco Targets Ther Year: 2017 Document type: Article Country of publication: New Zealand

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Onco Targets Ther Year: 2017 Document type: Article Country of publication: New Zealand